Pfizer shares sank Friday when the drugmaker said it would abandon a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it. The pharmaceutical company… [+1871 chars]Read More
Pfizer nixes more study of twicedaily obesity pill treatment that made many patients nauseous ABC News
